Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck

L Specht; S K Larsen; H S Hansen

Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck

L Specht, S K Larsen, H S Hansen

61 Citations (Scopus)

Abstract

Results with docetaxel as single drug in squamous-cell head and neck cancer have been encouraging. The purpose of the present phase II study is to evaluate the antitumour efficacy and toxicity of the combination of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck (SCCHN) for whom no curative therapy is available.

Original language	English
Journal	Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Volume	11
Issue number	7
Pages (from-to)	845-9
Number of pages	5
Publication status	Published - 1 Jul 2000

Cite this

Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck. / Specht, L; Larsen, S K; Hansen, H S.
In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 11, No. 7, 01.07.2000, p. 845-9.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{74b7864021974e90b0fce95c3bc85bdb,

title = "Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck",

abstract = "Results with docetaxel as single drug in squamous-cell head and neck cancer have been encouraging. The purpose of the present phase II study is to evaluate the antitumour efficacy and toxicity of the combination of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck (SCCHN) for whom no curative therapy is available.",

author = "L Specht and Larsen, \{S K\} and Hansen, \{H S\}",

year = "2000",

month = jul,

day = "1",

language = "English",

volume = "11",

pages = "845--9",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology / ESMO",

issn = "1569-8041",

publisher = "Elsevier Limited",

number = "7",

}

TY - JOUR

T1 - Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck

AU - Specht, L

AU - Larsen, S K

AU - Hansen, H S

PY - 2000/7/1

Y1 - 2000/7/1

N2 - Results with docetaxel as single drug in squamous-cell head and neck cancer have been encouraging. The purpose of the present phase II study is to evaluate the antitumour efficacy and toxicity of the combination of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck (SCCHN) for whom no curative therapy is available.

AB - Results with docetaxel as single drug in squamous-cell head and neck cancer have been encouraging. The purpose of the present phase II study is to evaluate the antitumour efficacy and toxicity of the combination of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck (SCCHN) for whom no curative therapy is available.

UR - https://www.scopus.com/pages/publications/0033816323

M3 - Journal article

C2 - 10997812

SN - 1569-8041

VL - 11

SP - 845

EP - 849

JO - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

JF - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

IS - 7

ER -

Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck

Abstract

Other files and links

Fingerprint

Cite this